Callum Matthews

Background

Callum joined the Dehns Biotechnology Group in 2019 after graduating from the University of Oxford with a first class MBiochem degree in Molecular and Cellular Biochemistry. During his final academic year, Callum carried out a research project in the Department of Biochemistry, which involved using Molecular Dynamics Simulations to investigate lipoprotein trafficking in bacteria.

Callum qualified as a European Patent Attorney in 2023.

Types of client and work

Callum works with a variety of clients, including small/medium-sized enterprises, universities and multinational companies. Callum handles prosecution of patent applications in Europe, and has experience of prosecution in a number of other jurisdictions including Canada, China, Japan, Korea, the UK and the US. Callum also assists with client work outside of prosecution, including freedom to operate analysis and patent application drafting.

Expertise

Callum has gained experience relating to a wide variety of technologies in the pharmaceutical and biotechnological fields, including recombinant DNA and protein products, antibodies, biosimilars, bioinformatics, stem cells, diagnostics assays, therapeutic treatments, virology and vaccines.

Qualification and Memberships

• European Patent Attorney, 2023
• PGCert (Intellectual Property Law), Queen Mary University of London, 2021
• Student Member of CIPA (Chartered Institute of Patent Attorneys)

Higher Education

MBiochem (Molecular and Cellular Biochemistry), University of Oxford, 2019